Epidemiology of hypertriglyceridaemia

Carlos Brotons; Irene Moral; Jara González; Diana Fernández; Mireia Puig; M Teresa Vilella

doi:10.1016/j.arteri.2020.12.015

Epidemiology of hypertriglyceridaemia

Clin Investig Arterioscler. 2021 May:33 Suppl 2:7-13. doi: 10.1016/j.arteri.2020.12.015.

[Article in English, Spanish]

Authors

Carlos Brotons¹, Irene Moral², Jara González², Diana Fernández², Mireia Puig², M Teresa Vilella²

Affiliations

¹ EAP Sardenya, Instituto de Investigaciones Biomédicas Sant Pau, Barcelona, España. Electronic address: cbrotons@eapsardenya.cat.
² EAP Sardenya, Instituto de Investigaciones Biomédicas Sant Pau, Barcelona, España.

PMID: 34006358
DOI: 10.1016/j.arteri.2020.12.015

Abstract

Based on the most recent scientific evidence, in this chapter we describe the relation of levels of triglycerides and risk of cardiovascular diseases. Particularly, we describe the prevalence of hypertriglyceridemia based on studies published at national and international reports; the relation between hypertriglyceridemia and cardiovascular diseases according to results of cohort studies; and finally, we describe the most recent evidence from clinical trials, meta-analysis and systematic reviews that have shown data on the efficacy of lowering triglyceride levels and reducing cardiovascular diseases.

Keywords: Epidemiology; Epidemiología; Triglicéridos; Triglycerides.

Publication types

Meta-Analysis

MeSH terms

Cardiovascular Diseases / epidemiology
Cardiovascular Diseases / etiology
Humans
Hyperlipidemias
Hypertriglyceridemia* / epidemiology
Risk Factors
Triglycerides

Substances

Triglycerides